Étiqueté : Genetics
Yellow Card Biobank: call to contribute to study of genetic links to side effects
Support this initiative to explore whether there is a genetic basis of side effects associated with direct-acting oral anticoagulants (DOACs) and allopurinol. Read the news from Medicines and Healthcare products Regulatory Agency published on 21...
Dépistages préconceptionnels : Faut-il tout savoir avant de concevoir un enfant ?
Les dépistages génétiques de porteurs sont des tests réalisés avant la conception pour les couples qui sont à risque de transmettre une maladie génétique à leur descendance. L’Hôpital Universitaire de Gand a récemment demandé au...
Corporate report – Code on Genetic Testing and Insurance: the government’s annual report 2023
The Code on Genetic Testing and Insurance (the code) was published in October 2018, replacing the Concordat and Moratorium on Genetics and Insurance. The code is a voluntary agreement between the government and the Association of British...
New mouse genetics funding to tackle human ageing, dementia and diseases
New funding brings UKRI investment into the National Mouse Genetics Network to £25 million. Age-related illnesses such as dementia are some of the most challenging disease areas we face. New UK Research and Innovation (UKRI)...
HFEA welcomes announcement on law changes to IVF provision in the UK
Law change announced regarding partner donation and gamete donation from those who have HIV with an undetectable viral load. When the law changes, this will mean in relation to reciprocal IVF that the egg provider...
Pioneering genetic biobank to start recruiting patients on stroke prevention medicines
The Yellow Card Biobank will today start investigating a new group of medicines known as Direct Oral Anticoagulants. Read the press release from Medicines and Healthcare products Regulatory Agency published on 13 February 2024.
Away from “one disease at a time”: New approaches to screening and drug development
A recent commentary published in the American Journal of Medical Genetics discusses the need to transition away from a “one disease at a time” model in newborn screening and drug development, and potential strategies for addressing this...
Current and future therapeutics for paediatric genetic diseases
A study has been published in Singapore Medical Journal providing an overview of the existing treatment strategies for paediatric genetic diseases (PGDs), including recent advancements.
New judgment of 7 February 2023 from the Grand Chamber of the CJEU, Confédération paysanne and Others
The Grand Chamber of the Court of Justice of the European Union released a new judgment of 7 February 2023 on the case of Confédération paysanne and Others (In vitro random mutagenesis), C-688/21, about the...





